Publications by authors named "Jeffrey Szer"

Claim this Profile
S
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.
Christopher J Patriquin, Andrija Bogdanovic, Morag Griffin, Richard J Kelly, Jaroslaw P Maciejewski, Jeffrey Szer

Adv Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes.
Isaac Goncalves, Cameron Lewis, Brian Grainger, Rebecca Dring, Nora Lee, Jeffrey Szer

Res Pract Thromb Haemost· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Jeffrey Szer

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.
Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta, Jeffrey Szer

Hematol Oncol Stem Cell Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Sarah Schmidt, Ying Liu, Zhen-Huan Hu, Kirsten M Williams, Hillard M Lazarus, Jeffrey Szer

Biol Blood Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Robert Weinkove, Zoe K McQuilten, Jonathan Adler, Meera R Agar, Emily Blyth, Jeffrey Szer

Med J Aust· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Zachariah DeFilipp, Richard Ancheta, Ying Liu, Zhen-Huan Hu, Robert Peter Gale, Jeffrey Szer

Biol Blood Marrow Transplant· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta, Jeffrey Szer

Biol Blood Marrow Transplant· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Nicole L Prokopishyn, Brent R Logan, Deidre M Kiefer, Jennifer A Sees, Pintip Chitphakdithai, Jeffrey Szer

Biol Blood Marrow Transplant· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, Michael T Hemmer, Stephen R Spellman, Jeffrey Szer

Blood Adv· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Brian T Hill, Kwang Woo Ahn, Zhen-Huan Hu, Mahmoud Aljurf, Amer Beitinjaneh, Jeffrey Szer

Biol Blood Marrow Transplant· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
Hagop M Kantarjian, Pierre Fenaux, Mikkael A Sekeres, Jeffrey Szer, Uwe Platzbecker

Lancet Haematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development.
Yuval Ishay, Ari Zimran, Jeffrey Szer, Tama Dinur, Yaron Ilan

Blood Cells Mol Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model.
Matthew I Bellgard, Kathryn R Napier, Alan H Bittles, Jeffrey Szer, Sue Fletcher

Blood Cells Mol Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34 Yields Are Less.
David F Stroncek, Bronwen E Shaw, Brent R Logan, Deidre M Kiefer, Bipin N Savani, Jeffrey Szer

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.
Atul Mehta, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, Deborah Elstein, Jeffrey Szer

Mol Genet Metab· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Peter Martin, Zhengming Chen, Bruce D Cheson, Katherine S Robinson, Michael Williams, Jeffrey Szer

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Eric Wong, Kate Mason, Jenny Collins, Barbara Hockridge, Janis Boyd, Jeffrey Szer

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.
Bastian von Tresckow, Franck Morschhauser, Jeffrey Szer, Dennis A Eichenauer, Jeremy S Abramson

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
William Nigel Patton, Ian Nivison-Smith, Peter Bardy, Anthony Dodds, David Ma, Jeffrey Szer

Biol Blood Marrow Transplant· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.
Philip A Thompson, Travis Perera, David Marin, Betul Oran, Uday Popat, Jeffrey Szer

Leuk Lymphoma· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
Gregory M Pastores, Suma P Shankar, Milan Petakov, Pilar Giraldo, Hanna Rosenbaum, Jeffrey Szer

Am J Hematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.
Peter Hillmen, Petra Muus, Jeffrey Szer, Anita Hill, Britta Höchsmann

Am J Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
Tan N Doan, Carl M J Kirkpatrick, Patricia Walker, Monica A Slavin, Michelle R Ananda-Rajah, Jeffrey Szer

J Antimicrob Chemother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Edward A Copelan, Belinda R Avalos, Kwang Woo Ahn, Xiaochun Zhu, Robert Peter Gale, Jeffrey Szer

Biol Blood Marrow Transplant· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis